• Photosynthetic bacteria-based cancer opt

    From ScienceDaily@1337:3/111 to All on Tue Feb 16 21:30:44 2021
    Photosynthetic bacteria-based cancer optotheranostics

    Date:
    February 16, 2021
    Source:
    Japan Advanced Institute of Science and Technology
    Summary:
    Natural purple photosynthetic bacteria (PPSB) can play a key role
    as a highly active cancer immunotheranostics agent that uses the
    bio-optical- window I and II near-infrared (NIR) light. PPSB have
    high tumor specificity and non-pathogenicity. Active anticancer
    efficacy and powerful multi-functions such as NIR-I-to-NIR-II
    fluorescence, photothermal conversion, reactive oxygen species
    generation, and contrasty photoacoustic effect, can be expressed
    using NIR light exposure to PPSB.



    FULL STORY ========================================================================== Cancer is one of the most thought-provoking healthcare problems throughout
    the world. The development of therapeutic agents with highly selective anti-cancer activities is increasingly attractive due to the lack of
    tumor selectivity of conventional treatments.


    ========================================================================== Scientists at Japan Advanced Institute of Science and Technology (JAIST)
    have created a photosynthetic bacteria-based cancer optotheranostics.

    Discovered by Associate Professor Eijiro Miyako and his team from
    JAIST, natural purple photosynthetic bacteria (PPSB) can play a key
    role as a highly active cancer immunotheranostics agent that uses the bio-optical-window I and II near-infrared (NIR) light thanks to the light harvesting nanocomplexes in microbial membrane. The NIR light-driven
    PPSB would serve as an effective "all- in-one" theranostic material for
    use in deep tumor treatments.

    At least, the present work has the following great advantages in
    comparison with other cancer treatments such as anticancer drug,
    nanomedicine, antibody, and conventional microbial therapies.

    1) PPSB have high tumor specificity and non-pathogenicity; 2) Sufficient
    active cancer efficacy and multifunction such as NIR-I-to-NIR-II
    fluorescence (FL), photothermal conversion, reactive oxygen species (ROS) generation, and contrasty photoacoustic (PA) effect, can be simultaneously expressed using NIR light exposure without chemical functionalizations and genetic manipulations; 3) Complicated and expensive procedures for their production are unnecessary because they can be spontaneously proliferated
    by simple culturing in cheap medium.

    The present experiments warrant further consideration of this novel
    theranostic approach for the treatment of refractory cancers. The team
    believes that the developed technology would advance cancer treatment
    for creating more effective medicine.

    The work was supported by the Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research (A) and the KAKENHI Fund
    for the Promotion of Joint International Research.

    ========================================================================== Story Source: Materials provided by Japan_Advanced_Institute_of_Science_and_Technology. Note: Content may
    be edited for style and length.


    ========================================================================== Journal Reference:
    1. Xi Yang, Satoru Komatsu, Sheethal Reghu, Eijiro Miyako. Optically
    activatable photosynthetic bacteria-based highly tumor specific
    immunotheranostics. Nano Today, 2021; 37: 101100 DOI: 10.1016/
    j.nantod.2021.101100 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2021/02/210216094314.htm

    --- up 9 weeks, 7 hours, 57 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)